Filtered By:
Vaccination: Cervical Cancer Vaccine

This page shows you your search results in order of relevance. This is page number 12.

Order by Relevance | Date

Total 2139 results found since Jan 2013.

The Role of Vaccination Interventions to Promote HPV Vaccine Uptake Rates in a College-Aged Population: a Systematic Review
AbstractThis systematic review provided synthesized evidence regarding the effectiveness of the interventions promoting the human papillomavirus (HPV) vaccination in college-aged population. The HPV infection is the most prevailing sexually transmitted disease. Despite the availability and effectiveness of the 9-Valent HPV vaccine, the vaccine coverage among young adults remained low. In witness to the increasing burden of HPV-related infections and cancers, research focused on the vaccination interventions should be conducted to determine the effectiveness of the vaccination strategy and address the gap. The search was co...
Source: Journal of Cancer Education - June 20, 2020 Category: Cancer & Oncology Source Type: research

Anti-viral therapy for the sexually transmitted viruses: recent updates on vaccine development.
Authors: Kardani K, Basimi P, Fekri M, Bolhassani A Abstract INTRODUCTION: The sexually transmitted infections (STIs) caused by viruses including human T cell leukemia virus type-1 (HTLV-1), human immunodeficiency virus-1 (HIV-1), human simplex virus-2 (HSV-2), hepatitis C virus (HCV), hepatitis B virus (HBV), and human papillomavirus (HPV) are major public health issues. These infections can cause cancer or result in long-term health problems. Due to high prevalence of STIs, a safe and effective vaccine is required to overcome these fatal viruses. AREAS COVERED: This review includes a comprehensive overview of...
Source: Expert Review of Clinical Pharmacology - August 27, 2020 Category: Drugs & Pharmacology Tags: Expert Rev Clin Pharmacol Source Type: research

Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer
Basel, 16 September 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval for the expanded use of CINtec®PLUS Cytology, the first triage test based on biomarker technology for women whose cervical cancer screening results are positive for high-risk types of human papillomavirus (HPV). Additional information from this test supports clinical decisions about which women will benefit most from immediate follow-up. Laboratories can now use CINtecPLUS Cytology to triage positive results from the cobas ® HPV Test run on the fully integrated, automated and high-throughput co...
Source: Roche Media News - September 16, 2020 Category: Pharmaceuticals Source Type: news

A Study of Human Papillomavirus Genotypes Specificity and the Vaccines Introducing System for Korean-Chinese Women in the Yanbian Autonomous Region.
CONCLUSIONS: Gardasil® 9 should be the most suitable vaccine for Korean-Chinese women with HPV infection and cervical cancer in this region considering the prevalence of certain genotypes. Governments and medical institutions should take an active stance on HPV vaccination to lower the incidence of cervical cancer here. Our study may serve as an important reference for introducing a Chinese government program designed to prevent cervical cancer. PMID: 33247692 [PubMed - as supplied by publisher]
Source: Asian Pacific Journal of Cancer Prevention - November 30, 2020 Category: Cancer & Oncology Tags: Asian Pac J Cancer Prev Source Type: research

Prevalence of Human Papillomavirus (HPV) DNA among Men with Oropharyngeal and Anogenital Cancers: A Systematic Review and Meta-Analysis
CONCLUSION: Higher pooled prevalence of HPV DNA was observed among men with oropharyngeal and penile cancers. Multicentric molecular studies investigating the prevalence of HPV in prostate cancers have to be planned in future.PMID:34048162 | DOI:10.31557/APJCP.2021.22.5.1351
Source: Asian Pacific Journal of Cancer Prevention - May 28, 2021 Category: Cancer & Oncology Authors: Sabeena Sasidharanpillai Nagaraja Ravishankar Veena Kamath Parvati Vinod Bhat Puneet Bhatt Govindakarnavar Arunkumar Source Type: research